Randomized controlled study of GnRH antagonist monotherapy and CAB with GnRH agonist plus bicalutamide for patients with metastatic prostate cancer.
Phase 3
- Conditions
- metastatic prostate cancer
- Registration Number
- JPRN-UMIN000014243
- Lead Sponsor
- Clinical Research Support Center Kyushu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with history of treatment or under treatment on prostate cancer. 2. Patients with active double cancer. Patients with history of malignant tumor within the past 5 years are regarded as having active double cancer. The basal cell carcinoma that radical treatment was taken or superficial squamous cell carcinoma are not included in active double cancer.) 3. Patients with less than 20 years of age on the enrollment day. 4. Any other patients who are regarded as unsuitable for this study by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method